Olga Milo-Cotter Selected Research

Body Weight (Weight, Body)

1/2008

Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olga Milo-Cotter Research Topics

Disease

7	Heart Failure 01/2011 - 08/2004
2	Dyspnea (Shortness of Breath) 01/2010 - 08/2004
2	Left Ventricular Dysfunction 01/2008 - 03/2006
2	Hemorrhage 10/2007 - 01/2006
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2010
1	Hypertension (High Blood Pressure) 12/2009
1	Cardiogenic Shock 03/2008
1	Reperfusion Injury 03/2008
1	Body Weight (Weight, Body) 01/2008
1	Pulmonary Hypertension 01/2008
1	Atrial Fibrillation 02/2007
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2006
1	Hypotension (Low Blood Pressure) 11/2005
1	Ischemia 11/2005
1	Cardiomyopathies (Cardiomyopathy) 11/2005

Drug/Important Bio-Agent (IBA)

2	tezosentanIBA 01/2011 - 08/2004
2	TroponinIBA 01/2011 - 11/2005
2	Pharmaceutical PreparationsIBA 01/2010 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2010 - 02/2008
2	Dobutamine FDA LinkGeneric 03/2006 - 11/2005
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	C-Reactive ProteinIBA 01/2011
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2011
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	von Willebrand FactorIBA 01/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	CytokinesIBA 01/2011
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2011
1	ChemokinesIBA 01/2011
1	Endothelin-1 (Endothelin 1)IBA 01/2011
1	Vasodilator Agents (Vasodilators)IBA 12/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2008
1	Hemoglobins (Hemoglobin)IBA 01/2008
1	Bosentan (Tracleer)FDA Link 01/2008
1	DiureticsIBA 01/2008
1	bivalirudin (Angiomax)FDA Link 10/2007
1	AntithrombinsIBA 10/2007
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2007
1	Heparin (Liquaemin)FDA LinkGeneric 10/2007
1	Urea (Carbamide)FDA LinkGeneric 02/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2006
1	SuspensionsIBA 11/2005
1	Endothelins (Endothelin)IBA 08/2004

Therapy/Procedure

2	Therapeutics 01/2010 - 03/2008
1	Length of Stay 01/2010
1	Percutaneous Coronary Intervention 01/2006